Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive

Journal of Ayurveda and Integrative Medicine

Volumn 7, Issue 3, 2016, Pages 173-180

  Majdalawieh, Amin F ^a   Fayyad, Muneera W ^a  

^a AMERICAN UNIVERSITY OF SHARJAH   (United Arab Emirates)

Author keywords

Anti cancer; Apoptosis; Cytotoxicity; Nigella sativa; NK cytotoxic activity

Indexed keywords

ANTINEOPLASTIC AGENT; FOOD ADDITIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NIGELLA SATIVA EXTRACT;

ANTIMUTAGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BLACK CUMIN; CANCER CELL; CANCER CELL LINE; CANCER INCIDENCE; CANCER RESEARCH; CARCINOGENESIS; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS INHIBITION; NATURAL KILLER CELL; NONHUMAN; PLANT SEED; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84991728746     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.1016/j.jaim.2016.07.004     Document Type: Review

References (117)

1. [1] Barrett, B., Kiefer, D., Rabago, D., Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med 5 (1999), 40–49.
2. [2] Donaldson, K., Introduction to the healing herbs. ORL Head Neck Nurs 16 (1998), 9–16.
3. [3] de Souza Grinevicius, V.M., Kviecinski, M.R., Santos Mota, N.S., Ourique, F., Porfirio Will Castro, L.S., Andreguetti, R.R., et al. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells. J Ethnopharmacol 189 (2016), 139–147.
4. [4] Lam, M., Carmichael, A.R., Griffiths, H.R., An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression. PLoS One, 7(6), 2012, e40152.
5. [5] Siao, A.C., Hou, C.W., Kao, Y.H., Jeng, K.C., Effect of sesamin on apoptosis and cell cycle arrest in human breast cancer mcf-7 cells. Asian Pac J Cancer Prev 16:9 (2015), 3779–3783.
6. [6] Banerjee, S., Azmi, A.S., Padhye, S., Singh, M.W., Baruah, J.B., Philip, P.A., et al. Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer. Pharm Res 27:6 (2010), 1146–1158.
7. [7] Khan, M.A., Chen, H.C., Tania, M., Zhang, D.Z., Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Altern Med 8:5 Suppl (2011), 226–232.
8. [8] Ali, B.H., Blunden, G., Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17:4 (2003), 299–305.
9. [9] Salem, M.L., Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 5 (2005), 1749–1770.
10. [10] Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed 3:5 (2013), 337–352.
11. [11] Butt, M.S., Sultan, M.T., Nigella sativa: reduces the risk of various maladies. Crit Rev Food Sci Nutr 50:7 (2010), 654–665.
12. [12] Banerjee, S., Padhye, S., Azmi, A., Wang, Z., Philip, P.A., Kucuk, O., et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 62:7 (2010), 938–946.
13. [13] Randhawa, M., Alghamdi, M., Anticancer activity of Nigella sativa (black seed) - a review. Am J Chin Med 39:6 (2011), 1075–1091.
14. [14] Woo, C.C., Kumar, A.P., Sethi, G., Tan, K.H., Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol 83:4 (2012), 443–451.
15. [15] Shabana, A., El-Menyar, A., Asim, M., Al-Azzeh, H., Al Thani, H., Cardiovascular benefits of black cumin (Nigella sativa). Cardiovasc Toxicol 13:1 (2013), 9–21.
16. [16] Abukhader, M.M., Thymoquinone in the clinical treatment of cancer: fact or fiction?. Pharmacogn Rev 7:14 (2013), 117–120.
17. [17] Schneider-Stock, R., Fakhoury, I.H., Zaki, A.M., El-Baba, C.O., Gali-Muhtasib, H.U., Thymoquinone: fifty years of success in the battle against cancer models. Drug Discov Today 19:1 (2014), 18–30.
18. [18] Rahmani, A.H., Alzohairy, M.A., Khan, M.A., Aly, S.M., Therapeutic implications of black seed and its constituent thymoquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evid Based Complement Altern Med, 2014, 2014, 724658.
19. [19] Majdalawieh, A.F., Fayyad, M.W., Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review. Int Immunopharmacol 28 (2015), 295–304.
20. [20] Iddamaldeniya, S.S., Wickramasinghe, N., Thabrew, I., Ratnatunge, N., Thammitiyagodage, M.G., Protection against diethylnitrosoamine-induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra: a preliminary study. J Carcinog, 2(1), 2003, 6.
21. [21] Thabrew, M.I., Mitry, R.R., Morsy, M.A., Hughes, R.D., Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells. Life Sci 77:12 (2005), 1319–1330.
22. [22] Samarakoon, S.R., Thabrew, I., Galhena, P.B., De-Silva, D., Tennekoon, K.H., A comparison of the cytotoxic potential of standardized aqueous and ethanolic extracts of a polyherbal mixture comprised of Nigella sativa (seeds), Hemidesmus indicus (roots) and Smilax glabra (rhizome). Pharmacogn Res 2 (2010), 335–342.
23. [23] Iddamaldeniya, S.S., Thabrew, M.I., Wickramasinghe, S.M., Ratnatunge, N., Thammitiyagodage, M.G., A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra. J Carcinog, 5, 2006, 11.
24. [24] Salomi, N.J., Nair, S.C., Jayawardhanan, K.K., Varghese, C.D., Panikkar, K.R., Antitumour principles from Nigella sativa seeds. Cancer Lett 63 (1992), 41–46.
25. [25] Salomi, M.J., Nair, S.C., Panikkar, K.R., Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer 16 (1991), 67–72.
26. [26] Farah, I.O., Begum, R.A., Effect of Nigella sativa (N. sativa L.) and oxidative stress on the survival pattern of MCF-7 breast cancer cells. Biomed Sci Instrum 39 (2003), 359–364.
27. [27] Salim, E.I., Fukushima, S., Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis. Nutr Cancer 45:2 (2003), 195–202.
28. [28] Abd El-Aziz, M.A., Hassan, H.A., Mohamed, M.H., Meki, A.M.A., Abdel-Ghaffar, S.K.H., Hussein, M.R., The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model. Int J Exp Pathol 86:6 (2005), 383–396.
29. [29] Ait Mbarek, M., Ait Mouse, H., Elabbadi, N., Bensalah, M., Gamouh, A., Aboufatima, R., et al. Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res 40 (2007), 839–847.
30. [30] Fathy, M., Nikaido, T., In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa. Env Health Prev Med 18:5 (2013), 377–385.
31. [31] Abdel-Hamid, N.M., Abdel-Ghany, M.I., Nazmy, M.H., Amgad, S.W., Can methanolic extract of Nigella sativa seed affect glyco-regulatory enzymes in experimental hepatocellular carcinoma?. Environ Health Prev Med 18:1 (2013), 49–56.
32. [32] Khan, F., Kalamegam, G., Gari, M., Abuzenadah, A., Chaudhary, A., Al Qahtani, M., et al. Evaluation of the effect of Nigella sativa extract on human hepatocellular adenocarcinoma cell line (HepG2) in vitro. BMC Genomics, 15(Suppl. 2), 2014, 63.
33. [33] Swamy, S.M., Tan, B.K., Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J Ethnopharmacol 70 (2000), 1–7.
34. [34] Mabrouk, G.M., Moselhy, S.S., Zohny, S.F., Ali, E.M., Helal, T.E., Amin, A.A., et al. Inhibition of methylnitrosourea (MNU) induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawely rats. J Exp Clin Cancer Res 21 (2002), 341–346.
35. [35] Zaoui, A., Cherrah, Y., Mahassini, N., Alaoui, K., Amarouch, H., Hassar, M., Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9:1 (2002), 69–74.
36. [36] Islam, S.N., Begum, P., Ahsan, T., Huque, S., Ahsan, M., Immunosuppressive and cytotoxic properties of Nigella sativa. Phytother Res 18 (2004), 395–398.
37. [37] Ali, B.H., The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats. Am J Chin Med 32 (2004), 49–55.
38. [38] Alenzi, F.Q., El-Bolkiny, Yel-S., Salem, M.L., Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci 67:1 (2010), 20–28.
39. [39] Ebaid, H., Dkhil, M., Zahran, W., Feki, M., Gabry, M., Role of Nigella sativa in ameliorating chloramphenicol induced tissue damage in rats. J Med Plants Res 5:2 (2011), 280–288.
40. [40] Dollah, M.A., Parhizkar, S., Latiff, L.A., Bin Hassan, M.H., Toxicity effect of Nigella sativa on the liver function of rats. Adv Pharm Bull 3:1 (2013), 97–102.
41. [41] Hadi, V., Kheirouri, S., Alizadeh, M., Khabbazi, A., Hosseini, H., Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed 6:1 (2016), 34–43.
42. [42] Khader, M., Eckl, P.M., Bresgen, N., Effects of aqueous extracts of medicinal plants on MNNG-treated rat hepatocytes in primary cultures. J Ethnopharmacol 112:1 (2007), 199–202.
43. [43] Khader, M., Bresgen, N., Eckl, P.M., Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. J Ethnopharmacol 127:2 (2010), 319–324.
44. [44] Awad, E.M., In vitro decreases of the fibrinolytic potential of cultured human fibrosarcoma cell line, HT1080, by Nigella sativa oil. Phytomedicine 129:1–2 (2005), 100–107.
45. [45] Elkadi, A., Kandil, O., Effect of Nigella sativa (the black seed) on immunity. Proceeding of the 4th International Conference on Islamic Medicine, Kuwait, Bull Islamic Med 4 (1986), 344–348.
46. [46] El-Kadi, A., Kandil, O., Tabuni, A.M., Nigella sativa and cell mediated immunity. Arch AIDS Res 1 (1989), 232–233.
47. [47] Abuharfeil, N.M., Maraqa, A., Von Kleist, S., Augmentation of natural killer cell activity in vitro against tumor cells by wild plants from Jordan. J Ethnopharmacol 71 (2000), 55–63.
48. [48] Abuharfeil, N.M., Salim, M., Von Kleist, S., Augmentation of natural killer cell activity in vivo against tumour cells by some wild plants from Jordan. Phytother Res 15 (2001), 109–113.
49. [49] Shabsoug, B., Khalil, R., Abuharfeil, N., Enhancement of natural killer cell activity in vitro against human tumor cells by some plants from Jordan. J Immunotoxicol 5 (2008), 279–285.
50. [50] Majdalawieh, A.F., Hmaidan, R., Carr, R.I., Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity. J Ethnopharmacol 131 (2010), 268–275.
51. [51] Majdalawieh, A.F., Carr, R.I., In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food 13 (2010), 371–381.
52. [52] Salem, M.L., Hossain, M.S., Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol 22 (2000), 729–740.
53. [53] Houghton, P.J., Zarka, R., de las Heras, B., Hoult, J.R., Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61 (1995), 33–36.
54. [54] Swamy, S.M., Huat, B.T., Intracellular glutathione depletion and reactive oxygen species generation are important in alpha-hederin-induced apoptosis of P388 cells. Mol Cell Biochem 245 (2003), 127–139.
55. [55] Chehl, N., Chipitsyna, G., Gong, Q., Yeo, C.J., Arafat, H.A., Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB Oxf 11:5 (2009), 373–381.
56. [56] Rastogi, L., Feroz, S., Pandey, B.N., Jagtap, A., Mishra, K.P., Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. Int J Radiat Biol 86:9 (2010), 719–731.
57. [57] Velho-Pereira, R., Kumar, A., Pandey, B., Mishra, K., Jagtap, A., Radioprotection by macerated extract of Nigella sativa in normal tissues of fibrosarcoma bearing mice. Indian J Pharm Sci 74:5 (2012), 403–414.
58. [58] Sultan, M.T., Butt, M.S., Karim, R., Ahmad, N., Ahmad, R.S., Ahmad, W., Nigella sativa fixed and essential oil improves antioxidant status through modulation of antioxidant enzymes and immunity. Pak J Pharm Sci 28:2 (2015), 589–595.
59. [59] Nieto, N., Torres, M.I., Fernandez, M.I., Giron, M.D., Rios, A., Suarez, M.D., et al. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 45 (2000), 1820–1827.
60. [60] Koch, T.R., Yuan, L.X., Stryker, S.J., Ratliff, P., Telford, G.L., Opara, E.C., Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 45 (2000), 1814–1819.
61. [61] Choudhary, S., Keshavarzian, A., Yong, S., Wade, M., Bocckino, S., Day, B.J., et al. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci 46 (2001), 2222–2230.
62. [62] Al-Ghamdi, M.S., The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 76 (2001), 45–48.
63. [63] El-Dakhakhny, M., Madi, N.J., Lembert, N., Ammon, H.P., Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 81 (2002), 161–164.
64. [64] Mahgoub, A.A., Thymoquinone protects against experimental colitis in rats. Toxicol Lett 143 (2003), 133–143.
65. [65] Chakrabarty, A., Emerson, M.R., LeVine, S.M., Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult Scler 9 (2003), 372–381.
66. [66] Mansour, M., Tornhamre, S., Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib Med Chem 19 (2004), 431–436.
67. [67] Mohamed, A., Afridi, D.M., Garani, O., Tucci, M., Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis. Biomed Sci Instrum 41 (2005), 388–393.
68. [68] El-Gouhary, I., Mohamed, A., Suleiman, S., Benghuzzi, H., Comparison of the amelioration effects of two enzyme inducers on the inflammatory process of experimental allergic encephalitis (EAE) using immunohistochemical technique. Biomed Sci Instrum 41 (2005), 376–381.
69. [69] Sayed, A.A., Morcos, M., Thymoquinone decreases AGE-induced NF-kappaB activation in proximal tubular epithelial cells. Phytother Res 21 (2007), 898–899.
70. [70] El Gazzar, M.A., Thymoquinone suppresses in vitro production of IL-5 and IL-13 by mast cells in response to lipopolysaccharide stimulation. Inflamm Res 56 (2007), 345–351.
71. [71] Sayed, A.A., Thymoquinone protects renal tubular cells against tubular injury. Cell Biochem Funct 26 (2008), 374–380.
72. [72] Sethi, G., Ahn, K.S., Aggarwal, B.B., Targeting nuclear factor-{kappa}B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6 (2008), 1059–1070.
73. [73] Nikakhlagh, S., Rahim, F., Hossein, F., Aryani, N., Syahpoush, A., Brougerdnya, M., et al. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryng 32:5 (2001), 402–407.
74. [74] Duncker, S.C., Philippe, D., Martin-Paschoud, C., Moser, M., Mercenier, A., Nutten, S., Nigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors. PLoS One, 7(6), 2012, e39841.
75. [75] Yousefi, M., Barikbin, B., Kamalinejad, M., Abolhasani, E., Ebadi, A., Younespour, S., et al. Comparison of therapeutic effect of topical Nigella with betamethasone and eucerin in hand eczema. J Eur Acad Dermatol Venereol 27:12 (2013), 1498–1504.
76. [76] Abdel-Aziz, M., Abass, A., Zalata, K., Abd Al-Galel, T., Allam, U., Karrouf, G., Effect of dexamethasone and Nigella sativa on inducible nitric oxide synthase in the lungs of a murine model of allergic asthma. Iran J Allergy Asthma Immunol 13:5 (2014), 324–334.
77. [77] Keyhanmanesh, R., Pejman, L., Omrani, H., Mirzamohammadi, Z., Shahbazfar, A.A., The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in Guinea pig model of asthma. Bioimpacts 4:2 (2014), 75–81.
78. [78] Keyhanmanesh, R., Nazemiyeh, H., Mazouchian, H., Bagheri Asl, M.M., Karimi Shoar, M., Alipour, M.R., et al. Nigella sativa pretreatment in Guinea pigs exposed to cigarette smoke modulates in vitro tracheal responsiveness. Iran Red Crescent Med J, 16(7), 2014, e10421.
79. [79] Mahmood, M.S., Gilani, A.H., Khwaja, A., Rashid, A., Ashfaq, M.K., The in vitro effect of aqueous extract of Nigella sativa seeds on nitric oxide production. Phytother Res 17:8 (2003), 921–924.
80. [80] Al-Naggar, T.B., Gómez-Serranillos, M.P., Carretero, M.E., Villar, A.M., Neuropharmacological activity of Nigella sativa L. extracts. J Ethnopharmacol 88:1 (2003), 63–68.
81. [81] Ghannadi, A., Hajhashemi, V., Jafarabadi, H., An investigation of the analgesic and anti-inflammatory effects of Nigella sativa seed polyphenols. J Med Food 8:4 (2005), 488–493.
82. [82] Vaillancourt, F., Silva, P., Shi, Q., Fahmi, J., Fernandes, C., Benderdour, M., Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. Cell Biochem 112 (2001), 107–117.
83. [83] Shoieb, A.M., Elgayyar, M., Dudrick, P.S., Bell, J.L., Tithof, P.K., In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22 (2003), 107–113.
84. [84] Gali-Muhtasib, H., Diab-Assaf, M., Boltze, C., Al-Hmaira, J., Hartig, R., Roessner, A., et al. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 25 (2004), 857–866.
85. [85] Gali-Muhtasib, H., Kuester, D., Mawrin, C., Bajbouj, K., Diestel, A., Ocker, M., et al. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res 68 (2008), 5609–5618.
86. [86] Gali-Muhtasib, H., Ocker, M., Kuester, D., Krueger, S., El-Hajj, Z., Diestel, A., et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J Cell Mol Med 12 (2008), 330–342.
87. [87] Gali-Muhtasib, H.U., Abou Kheir, W.G., Kheir, L.A., Darwiche, N., Crooks, P.A., Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 15 (2004), 389–399.
88. [88] Hoque, A., Lippman, S.M., Wu, T.T., Xu, Y., Liang, Z.D., Swisher, S., et al. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26 (2005), 785–791.
89. [89] El-Mahdy, M.A., Zhu, Q., Wang, Q.E., Wani, G., Wani, A.A., Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 117 (2005), 409–417.
90. [90] Roepke, M., Diestel, A., Bajbouj, K., Walluscheck, D., Schonfeld, P., Roessner, A., et al. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 6 (2007), 160–169.
91. [91] Kaseb, A.O., Chinnakannu, K., Chen, D., Sivanandam, A., Tejwani, S., Menon, M., et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res 67 (2007), 7782–7788.
92. [92] El-Najjar, N., Chatila, M., Moukadem, H., Vuorela, H., Ocker, M., Gandesiri, M., et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15:2 (2010), 183–195.
93. [93] Badr, G., Alwasel, S., Ebaid, H., Mohany, M., Alhazza, I., Perinatal supplementation with thymoquinone improves diabetic complications and T cell immune responses in rat offspring. Cell Immunol 267:2 (2011), 133–140.
94. [94] Badr, G., Mohany, M., Abu-Tarboush, F., Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XL expression. Lipids Health Dis, 10, 2011, 236.
95. [95] Dergarabetian, E.M., Ghattass, K.I., El-Sitt, S.B., Al-Mismar, R.M., El-Baba, C.O., Itani, W.S., et al. Thymoquinone induces apoptosis in malignant T-cells via generation of ROS. Front Biosci Elite Ed 5 (2013), 706–719.
96. [96] Attoub, S., Sperandio, O., Raza, H., Arafat, K., Al-Salam, S., Al Sultan, M.A., et al. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam Clin Pharm 27:5 (2013), 557–569.
97. [97] Alhazmi, M.I., Hasan, T.N., Shafi, G., Al-Assaf, A.H., Alfawaz, M.A., Alshatwi, A.A., Roles of p53 and caspases in induction of apoptosis in MCF- 7 breast cancer cells treated with a methanolic extract of Nigella sativa seeds. Asian Pac J Cancer Prev 15:22 (2014), 9655–9660.
98. [98] Ichwan, S.J., Al-Ani, I.M., Bilal, H.G., Suriyah, W.H., Taher, M., Ikeda, M.A., Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines. Chin J Physiol 57:5 (2014), 249–255.
99. [99] El-Baba, C., Mahadevan, V., Fahlbusch, F.B., SM, S., Rau, T.T., Gali-Muhtasib, H., et al. Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. Mol Cancer, 13(1), 2014, 201.
100. [100] Salim, L.Z., Othman, R., Abdulla, M.A., Al-Jashamy, K., Ali, H.M., Hassandarvish, P., et al. Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo and in vitro. PLoS One, 9(12), 2014, e115340.
101. [101] Shafi, G., Munshi, A., Hasan, T.N., Alshatwi, A.A., Jyothy, A., Lei, D.K., Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell Int, 9, 2009, 29.
102. [102] Kumara, S.S., Huat, B.T., Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med 67:1 (2001), 29–32.
103. [103] Villani, P., Orsière, T., Sari-Minodier, I., Bouvenot, G., Botta, A., In vitro study of the antimutagenic activity of alphahederin. Ann Biol Clin Paris 59:3 (2001), 285–289.
104. [104] Rooney, S., Ryan, M.F., Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res 25:3B (2005), 2199–2204.
105. [105] Rooney, S., Ryan, M.F., Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells. Anticancer Res 25:6B (2005), 4255–4259.
106. [106] Bun, S.S., Elias, R., Baghdikian, B., Ciccolini, J., Ollivier, E., Balansard, G., Alpha-hederin potentiates 5-FU antitumor activity in human colon adenocarcinoma cells. Phytother Res 22:10 (2008), 1299–1302.
107. [107] Cheng, L., Xia, T.S., Wang, Y.F., Zhou, W., Liang, X.Q., Xue, J.Q., et al. The anticancer effect and mechanism of α-hederin on breast cancer cells. Int J Oncol 45:2 (2014), 757–763.
108. [108] Worthen, D.R., Ghosheh, O.A., Crooks, P.A., The in vitro antitumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res 18 (1998), 1527–1532.
109. [109] Kruk, I., Michalska, T., Lichszteld, K., Kładna, A., Aboul-Enein, H.Y., The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 41:7 (2000), 1059–1064.
110. [110] Marsik, P., Kokoska, L., Landa, P., Nepovim, A., Soudek, P., Vanek, T., In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 71:8 (2005), 739–742.
111. [111] Ivankovic, S., Stojkovic, R., Jukic, M., Milos, M., Milos, M., Jurin, M., The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Exp Oncol 28 (2006), 220–224.
112. [112] Tesarova, H., Svobodova, B., Kokoska, L., Marsik, P., Pribylova, M., Landa, P., et al. Determination of oxygen radical absorbance capacity of black cumin (Nigella sativa) seed quinone compounds. Nat Prod Commun 6:2 (2011), 213–216.
113. [113] Archana, P.R., Nageshwar Rao, B., Satish Rao, B.S., Modulation of gamma ray-induced genotoxic effect by thymol, a monoterpene phenol derivative of cymene. Integr Cancer Ther 10:4 (2011), 374–383.
114. [114] Deb, D.D., Parimala, G., Saravana Devi, S., Chakraborty, T., Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem Biol Interact 193:1 (2011), 97–106.
115. [115] Satooka, H., Kubo, I., Effects of thymol on B16-F10 melanoma cells. J Agric Food Chem 60:10 (2012), 2746–2752.
116. 2+]i rise and apoptosis in human glioblastoma cells. Life Sci 90:17–18 (2012), 703–711.
117. [117] Horvathova, E., Navarova, J., Galova, E., Sevcovicova, A., Chodakova, L., Snahnicanova, Z., et al. Assessment of antioxidative, chelating, and DNA-protective effects of selected essential oil components (eugenol, carvacrol, thymol, borneol, eucalyptol) of plants and intact Rosmarinus officinalis oil. J Agric Food Chem 62:28 (2014), 6632–6639.